David Patience

CIK: 0001970009

Transaction Breakdown

Open Market Buys (P)2 (20.0%)

High conviction signal

Open Market Sales (S)2 (20.0%)

Position reduction

Option Exercises (M)2 (20.0%)

Derivative conversions

Awards (A)3 (30.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (10.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

TLSI

TriSalus Life Sciences, Inc.

Officer

AXDX

Accelerate Diagnostics, Inc

Officer

Discretionary Trading P&L

Holdings

Transaction History (10 total)

TLSI
TriSalus Life Sciences, Inc.
Jul 1, 2026
Tax Payment(F)
Direct
14.7K shares at avg. $4.46$65K
TLSI
TriSalus Life Sciences, Inc.
May 15, 2026
Purchase(P)
Direct
7.1K shares at avg. $2.43$17K
TLSI
TriSalus Life Sciences, Inc.
Feb 23, 2026
Purchase(P)
Direct
3.7K shares at avg. $4.10$15K
TLSI
TriSalus Life Sciences, Inc.
Nov 24, 2025
Award(A)
Direct
65K shares-
TLSI
TriSalus Life Sciences, Inc.
Aug 28, 2025
Award(A)
Employee Stock Option (right to buy)
Direct
248.9K shares-
TLSI
TriSalus Life Sciences, Inc.
Aug 14, 2025
Award(A)
Direct
200K shares-
AXDX
Accelerate Diagnostics, Inc
Apr 1, 2025
Sale(S)
Direct
6.8K shares at avg. $0.71$5K
AXDX
Accelerate Diagnostics, Inc
Apr 1, 2025
Exercise(M)
Direct
20K shares-
AXDX
Accelerate Diagnostics, Inc
Feb 26, 2025
Sale(S)
Direct
535 shares at avg. $1.09$583.15
AXDX
Accelerate Diagnostics, Inc
Feb 26, 2025
Exercise(M)
Direct
1.5K shares-

		Type	Shares	Price		Ownership
Jul 1, 2026	TLSI TriSalus Life Sciences, Inc.	Tax Payment(F)	14,650	$4.46	$65,339	Direct
May 15, 2026	TLSI TriSalus Life Sciences, Inc.	Purchase(P)	7,100	$2.43	$17,253	Direct
Feb 23, 2026	TLSI TriSalus Life Sciences, Inc.	Purchase(P)	3,657	$4.10	$14,994	Direct
Nov 24, 2025	TLSI TriSalus Life Sciences, Inc.	Award(A)	65,000	-	-	Direct
Aug 28, 2025	TLSI TriSalus Life Sciences, Inc.	Award(A) Employee Stock Option (right to buy)	248,899	-	-	Direct
Aug 14, 2025	TLSI TriSalus Life Sciences, Inc.	Award(A)	200,000	-	-	Direct
Apr 1, 2025	AXDX Accelerate Diagnostics, Inc	Sale(S)	6,816	$0.71	$4,839	Direct
Apr 1, 2025	AXDX Accelerate Diagnostics, Inc	Exercise(M)	20,000	-	-	Direct
Feb 26, 2025	AXDX Accelerate Diagnostics, Inc	Sale(S)	535	$1.09	$583	Direct
Feb 26, 2025	AXDX Accelerate Diagnostics, Inc	Exercise(M)	1,500	-	-	Direct

1-10 of 10 transactions

About Patience David

Patience David (SEC CIK 0001970009) files insider reports with the SEC as Chief Financial Officer of TriSalus Life Sciences, Inc. (TLSI) and Chief Financial Officer of Accelerate Diagnostics, Inc (AXDX).

Signal8 holds 9 ownership filings by Patience David (1 Form 3, 8 Form 4), filed between Feb 27, 2025 and Jul 6, 2026. Those filings report 10 transactions, from Feb 26, 2025 to Jul 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Patience David's filings is in WESTMINSTER, CO.

Recent filings by Patience David

Jul 1, 2026: Tax withholding of TLSI shares (Form 4, code F).
May 15, 2026: Open-market purchase of TLSI shares (Form 4, code P).
Feb 23, 2026: Open-market purchase of TLSI shares (Form 4, code P).
Nov 24, 2025: Grant or award of TLSI shares (Form 4, code A).
Aug 28, 2025: Grant or award of TLSI derivative securities (Form 4, code A).

Other insiders filing for TriSalus Life Sciences, Inc. (TLSI)

Cox Bryan F., Chief of Research
Marshak Richard, Chief Commercial Officer
Stevens Jennifer, Chief Regulatory Officer
Szela Mary T, CEO and President
Marshall Richard Henry, Chief Medical Officer
Wahlstrom Mats, Director

How to read Form 4 transaction codes